Related Experiment Video

Updated: May 14, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Phosphotyrosine signaling proteins that drive oncogenesis tend to be highly interconnected

Grigoriy Koytiger1, Alexis Kaushansky, Andrew Gordus

  • 1Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.

Molecular & Cellular Proteomics : MCP
|January 30, 2013
PubMed

Insights

Receptor tyrosine kinases (RTKs) drive cancer. This study maps RTK and adaptor protein interactions, revealing highly interconnected networks in cancer-driving proteins, suggesting new drug targets.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Receptor tyrosine kinases (RTKs) and their regulated proteins are key drivers of oncogenesis in many cancers.
  • Understanding RTK signaling networks is crucial for cancer research and therapeutic development.

Purpose of the Study:

  • To systematically map interactions between SH2/PTB domains and tyrosine phosphorylated sites on RTKs and adaptor proteins.
  • To investigate the network properties of these interactions in relation to cancer.

Main Methods:

  • Utilized protein microarrays for quantitative measurement of interactions.
  • Assessed interactions between human SH2/PTB domains and phosphorylated sites on RTKs and adaptor proteins.

Main Results:

  • Identified extensive high-affinity binding sites between adaptor proteins, similar to RTKs.
  • Demonstrated that cancer-driving proteins exhibit higher interconnectivity via SH2/PTB domain interactions compared to non-oncogenic proteins.

Conclusions:

  • Network topology, specifically connectivity, can help prioritize novel drug targets within RTK signaling pathways.
  • The findings provide insights into the molecular basis of RTK-driven oncogenesis and potential therapeutic strategies.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...